PharmaShots | Incisive News in 3 Shots

Subscribe Now

MediLink Therapeutics

MediLink Therapeutics Enters into a Collaboration and License Agreement with Roche to Develop and Commercialize YL211 for Solid Tumors

MediLink Therapeutics Enters into a Collaboration and License Agreement with Roche to Develop and Commercialize YL211 for Solid Tu...

January 3, 2024

MediLink Therapeutics Entered into a Collaboration and License Agreement with BioNTech to Develop Next-Generation Anti-Cancer Antibody-Drug Conjugate

MediLink Therapeutics Entered into a Collaboration and License Agreement with BioNTech to Develop Next-Generation Anti-Cancer Anti...

October 14, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us